In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 89 for your search:
Drug:  mycophenolate mofetil
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: PROSKIN 01, NCT00866684

2.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 35 and under
Sponsor: Other
Protocol IDs: MT2000-18, 9504M09637, NCT00176878

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 75
Sponsor: NCI, Other
Protocol IDs: 1813.00, NCI-2009-01532, P01CA078902, P30CA015704, FHCRC-1813.00, 5666, NCT00075478

4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 65 and under
Sponsor: NCI, Other
Protocol IDs: 1992.00, NCI-2010-00737, P01CA078902, K23HL084054, P01CA018029, P01HL036444, FHCRC-1992.00, 6170, NHLBI-K23-HL084054-01A1, NCT00322101

5.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Under 18
Sponsor: Other
Protocol IDs: CCLG-LCH-2006-02, EU-20619, UKCCSG-HLH-2004, EUDRACT-2005-002187-28, NCT00334672

6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 21
Sponsor: NCI, Other
Protocol IDs: 467, 2U01HL069294, BMTCTN-0501, FHCRC-2128.00, NCT00412360

7.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 72
Sponsor: NCI, Other
Protocol IDs: 09-073, NCT00928018

8.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 669, U01HL069294, BMT CTN 0802, U01 HL069294-06, NCT01002742

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: NCI, Other
Protocol IDs: CDR0000370797, CALGB-100102, NCT00085449

10.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 65
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: GCLLSG-CLL3X, EU-20554, MEDAC-FLUD.10/CLL, NCT00281983

11.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 30 and under
Sponsor: Other
Protocol IDs: L 9471, NCT00529360

12.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UMCC 2008.095, NCT00810602

13.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 65 and under
Sponsor: NCI, Other
Protocol IDs: 1383.00, NCI-2012-00670, P01CA078902, FHCRC-1383.00, NCI-G99-1538, NCT00003954

14.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: Under 75
Sponsor: NCI, Other
Protocol IDs: 1495.00, NCI-2012-00581, P30CA015704, FHCRC-1495.00, NCI-G00-1790, NCT00005851

15.

Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Closed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 1668.00, NCI-2012-00668, P30CA015704, P01CA018029, FHCRC-1668.00, NCT00078858

16.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 75 and under
Sponsor: NCI, Other
Protocol IDs: 1586.00, FHCRC-1586.00, NCI-H01-0080, CDR0000069042, NCT00027547

17.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 1641.00, NCI-2012-00591, P01CA018029, P30CA015704, FHCRC-1641.00, NCI-H01-0081, NCT00027820

18.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: NCI, Other
Protocol IDs: 1743.00, NCI-2011-00386, P30CA015704, FHCRC-1743.00, 5476, NCT00054353

19.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 1939.00, FHCRC-1939.00, CDR0000432959, 5987, NCT00119340

20.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: NCI, Other
Protocol IDs: CDR0000066639, J9845, R01CA067782, P30CA006973, JHOC-98070603, JHOC-9845, NCI-H98-0023, NCT00003572

21.

Phase: Phase II
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: CDR0000068212, MSGCC-0012, NCI-V00-1624, NCT00006350

22.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 1 to 80
Sponsor: NCI
Protocol IDs: CPMC-IRB-8462, CPMC-IRB-CAMP-25, NCI-G00-1897, NCT00008307

23.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 70 and under
Sponsor: NCI, Other
Protocol IDs: 1581.00, NCI-2010-00131, P30CA015704, P01CA078902, FHCRC-1581.00, 5235, NCI-H02-0087, NCT00036738

24.

Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: ECOG-E1902, NCT00045305, E1902

25.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 1667.00, NCI-2010-00166, FHCRC-1667.00, NCI-H02-0098, NCT00049504
1     
New Search